About Maco Pharma India Transfusion Solutions Private Limited
Data last updated:
Maco Pharma India Transfusion Solutions Private Limited is a foreign private limited company based in Delhi, India, a subsidiary of Gmpi Sas. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 September 2013.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2013FTC258426. Its GSTIN is 07AAICM8409N1ZW (Delhi).
The company has an authorised share capital of ₹18 Cr and a paid-up capital of ₹18 Cr. It is led by directors including Deepak Shankar and Frank Joachim Schonfeld.
Its last annual general meeting (AGM) was held on 03 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Office Unit No. 310 Rg Mall, Sector 9 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2023, the company reported a revenue of ₹11.32 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹1.65 Cr (net margin -14.6%) and EBITDA of -₹1.64 Cr (EBITDA margin -14.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 16% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Macopharma. Court records list 1 case involving the company, including 1 filed by the company. The company has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in December 2020. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 1 smaller; the largest is Onestep Healthcare Private Limited with revenue of ₹11.34 Cr.
The last known website on record is macopharma.com.
Company details
Contact details
Maco Pharma India Transfusion Solutions Private Limited's registered office is in Delhi, Delhi. Its website is macopharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressOffice Unit No. 310 Rg Mall, Sector 9 Rohini, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maco Pharma India Transfusion Solutions operates one associated brand: Macopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers blood processing disposables, equipment, and software for safer components. | macopharma.com |
Business activity
The main business activity of Maco Pharma India Transfusion Solutions is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Financials of Maco Pharma India Transfusion Solutions Private Limited
FY 2023 filings availableMaco Pharma India Transfusion Solutions Private Limited reported revenue of ₹11.32 Cr (down 8% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 725% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.4% | ||||
| Net Profit Margin | -14.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Board of directors of Maco Pharma India Transfusion Solutions Private Limited
Maco Pharma India Transfusion Solutions has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Shankar | Director | 28 Mar 2023 | 3 Years 7 Months | As last reported |
| Frank Joachim Schonfeld | Director | 05 Feb 2021 | 5 Years 8 Months | As last reported |
| Munish Aggarwal Also directs: Tattvam Valuers LLP, Tattvam Resolution Professionals LLP | Irp/Rp/Liquidator | 28 Dec 2023 | 2 Years 10 Months | As last reported |
Peer comparison
Maco Pharma India Transfusion Solutions Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Onestep Healthcare Private Limited | ₹11.34 Cr (FY 2025) | 12.0% | Bhopal, Madhya Pradesh, India | |||
| Neuracle Lifesciences Private Limited | ₹11.34 Cr (FY 2025) | 21.0% | Chandigarh, India | |||
| Maco Pharma India Transfusion Solutions Private Limitedthis company | ₹11.32 Cr (FY 2023) | -₹1.65 Cr | -14.6% | -8.0% | 3 | Delhi, India |
| Stratgen Healthcare Private Limited | ₹11.27 Cr (FY 2025) | -26.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Auditor
Maco Pharma India Transfusion Solutions Private Limited is audited by VIKAS GARG & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS GARG & CO | FY 2021 | 014541N |
Shareholding
The shareholding of Maco Pharma India Transfusion Solutions Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Deals & funding
Maco Pharma India Transfusion Solutions Private Limited has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in December 2020.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: Maco Pharma Sas Seller: Gmpb Sa |
| Dec 2020 | Rights issue | ₹11.14 Cr | Investors: GMPI SAS (Groupe Maco Pharma International), Maco Pharma Sas, Gmpb Sa |
| Mar 2018 | Rights issue | ₹3.16 Cr | Investors: GMPI SAS (Groupe Maco Pharma International), Gmpb Sa |
| Jun 2014 | Rights issue | ₹3.35 Cr | Investors: GMPI SAS (Groupe Maco Pharma International), Gmpb Sa |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maco Pharma India Transfusion Solutions Private Limited has 1 court case on record: 1 filed by Maco Pharma India Transfusion Solutions. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Chandigarh | Insolvency matter | Filed by the company against Marketwave Agencies Private Limited | Disposed |
To see the full case history of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maco Pharma India Transfusion Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maco Pharma India Transfusion Solutions Private Limited has a workforce of 3 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Maco Pharma India Transfusion Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICM8409N1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maco Pharma India Transfusion Solutions Private Limited, buy the company report.
Recent activity
Maco Pharma India Transfusion Solutions Private Limited has 11 board changes on record since 2014: 3 appointments and 8 cessations. The latest: Munish Aggarwal was appointed as Irp/Rp/Liquidator on 28 Dec 2023.
2 earlier events are in the company report.
Frequently asked questions
Maco Pharma India Transfusion Solutions is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Maco Pharma India Transfusion Solutions is a company under liquidation, formerly operating as a foreign private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 September 2013 and is registered under CIN U24230DL2013FTC258426. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Maco Pharma India Transfusion Solutions has 3 current directors:
- Deepak Shankar - Director
- Frank Joachim Schonfeld - Director
- Munish Aggarwal - Irp/Rp/Liquidator
The latest financial statements of Maco Pharma India Transfusion Solutions on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 03 July 2023. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Maco Pharma India Transfusion Solutions is U24230DL2013FTC258426. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maco Pharma India Transfusion Solutions has 1 court case on record: 1 filed by the company.
Maco Pharma India Transfusion Solutions was incorporated on 26 September 2013. It is registered with the Registrar of Companies, Delhi.
Maco Pharma India Transfusion Solutions has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in December 2020.
The peers of Maco Pharma India Transfusion Solutions by revenue are Onestep Healthcare Private Limited, Neuracle Lifesciences Private Limited, Stratgen Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Munish Aggarwal was appointed as Irp/Rp/Liquidator on 28 Dec 2023. Deepak Shankar ceased to be Additional Director on 02 Jul 2023. Abhinav Kaushik ceased to be Company Secretary on 30 Jun 2023. Maco Pharma India Transfusion Solutions has 11 board changes on record in total.
Maco Pharma India Transfusion Solutions can be reached through the website macopharma.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
